Home › Funds › Trails Edge Capital Partners, LP › OKUR

Trails Edge Capital Partners, LP position in OKUR

ONKURE THERAPEUTICS INC · Health Care

Trails Edge Capital Partners, LP reported holding 619,557 shares of OKUR (ONKURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.24% of its reported portfolio and ranking #38 among its reported holdings. Trails Edge Capital Partners, LP has disclosed OKUR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)619.56K sh
Reported value held$1.69M
Portfolio Weight0.24%
First reportedQ2 2026
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's OKUR position evolved

Trails Edge Capital Partners, LP first disclosed a stake in OKUR in Q2 2026 at 1,438,456 shares (US$6.6M). Across 2 filings, Trails Edge Capital Partners, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 619,557 shares valued at US$1.7M — a reduction of -818,899 shares quarter over quarter.. Notable position changes include a 57% trim in Q3 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.44M $6.56M New
Q3 2026 619.56K $1.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OKUR and 13F data

OKUR (ONKURE THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in OKUR — the largest reported positions include BVF INC/IL (US$14.8M), StepStone Group LP (US$12.1M), ACORN CAPITAL ADVISORS, LLC (US$7.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OKUR

All OKUR fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held OKUR?

Trails Edge Capital Partners, LP has disclosed OKUR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Trails Edge Capital Partners, LP's current position in OKUR?

As of Q3 2026, Trails Edge Capital Partners, LP holds 619.56K shares of OKUR (ONKURE THERAPEUTICS INC), valued at $1.69M, representing 0.24% of its reported portfolio and ranking #38.

Has Trails Edge Capital Partners, LP been buying or selling OKUR?

In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP reduced its position in OKUR.

Which other funds hold OKUR?

Other major institutional holders of OKUR include BVF INC/IL, StepStone Group LP, ACORN CAPITAL ADVISORS, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.